Does Estrogen Cause Breast Cancer? Dr. Felice Gersh on Hormone Therapy, Risk, and the Questions Women Need to AskDoes Estrogen Cause Breast Cancer? Dr. Felice Gersh on Hormone Therapy, Risk, and the Questions Women Need to Ask
The Synergee Podcast
Lori Esarey and Kelly Engelmann speak with Dr Felice Gersh about oestrogen, progesterone and breast cancer, comparing bioidentical and synthetic hormones and unpacking complex risk data. The conversation blends Lori’s personal cancer journey with detailed explanations of hormone receptors, metabolic health and the role of lifestyle in menopause care.
1:05:18•5 Oct 2026
Hormones, Breast Cancer and Tough Choices: Dr Felice Gersh Talks Risk and Reality
Episode Overview
- Human-identical estradiol and progesterone are distinguished from older synthetic hormone products, which may carry different breast cancer risks.
- Receptor-positive breast cancers can indicate tumour cells that behave more like normal breast cells and may be linked with a better prognosis.
- Bioidentical estradiol and progesterone, especially in cyclic regimens, are discussed as having neutral or possibly reduced breast cancer risk in observational data.
- Estradiol is described as central to metabolic health, influencing visceral fat, immune function, and the body’s inflammatory response.
- Hormone therapy is presented as one key piece of health, but only alongside foundational lifestyle work on sleep, stress, movement, nutrition, and social connection.
“What I can tell you is it’s not human identical estradiol and it is not human identical progesterone.”
What resources and support systems are available for sobriety? Here, that question expands into a wider conversation about women’s health, hormones, and fear around breast cancer. This Synergee Podcast episode centres on a frank chat between co-hosts Lori Esarey and Kelly Engelmann and OB-GYN and integrative medicine physician Dr Felice Gersh.
You’ll hear Lori share her own story of invasive ductal carcinoma, the anxiety of treatment decisions, and the emotional weight of choosing to go back on bioidentical hormone replacement therapy despite strong opposition from her traditional doctors. Dr Gersh steps in with clear, science-heavy explanations, but keeps them grounded in everyday concerns.
She bluntly states, “What I can tell you is it’s not human identical estradiol and it is not human identical progesterone,” when talking about what causes breast cancer, and repeatedly distinguishes bioidentical hormones from older synthetic products like Prem-Pro and medroxyprogesterone acetate. She walks through the Women’s Health Initiative data, newer studies such as the French E3N trial, and why different hormone formulations carry different risks.
You’ll also get a detailed breakdown of what “oestrogen receptor positive” and “progesterone receptor positive” actually mean, and why receptor-positive tumours may signal a better prognosis rather than proof that hormones caused the cancer. Dr Gersh explains how estradiol can support cell cohesiveness, metabolic health, and immune function, and why she sees hormones as “life hormones” rather than just tools for hot flushes.
Alongside the science, the trio keep circling back to practical realities: conflicting evidence, lack of definitive trials, the need for informed consent, and the crucial role of lifestyle—sleep, stress, movement, food, love and purpose—in any plan. If you’ve ever felt scared, confused, or silenced around hormone therapy after breast cancer, this conversation may help you frame better questions and push for more meaningful dialogue with your own clinicians.
What questions do you need to ask next time you’re in the consulting room?
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.